WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that Quell ® will be featured in the Target Open House in San Francisco . "We are delighted that Target has added Quell to their Open House concept," said Frank McGillin, SVP and General Manager, Consumer of
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) announced today that to celebrate having reached 10,000 fans for Quell ® Pain Relief on Facebook, it will give away a contest prize each day during September which is Pain Awareness Month.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today provided commentary on its Quell ® partnership strategy. The Company has five objectives for its Quell partnership strategy. Support NeuroMetrix efforts to build the Quell brand in the North America market Make Quell
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that the company, in partnership with Advantage Healthcare , will explore Quell ® retail expansion plans with executives from key national and regional drug chains and mass merchandisers at the NCADS Total Store
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) announced a major milestone with over 1 million hours of Quell ® therapy and health data uploaded to the Quell Health Cloud as of August 1, 2016 . Quell is a wearable therapeutic technology that provides drug-free relief from
Revenue Up 116% year-over-year to $2.6 Million 11,201 Quell Devices Shipped Expanded Retail Availability of Quell to over 1,500 retail stores WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter and six month periods
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2016 second quarter financial results before the opening of the market on Thursday July 21, 2016 . The Company will host a conference call at 8:00 a.m., Eastern Time on July 21, 2016 to
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. ( NURO ) today reported commercial expansion of DPNCheck ® in Mexico following receipt of a purchase order from one of Mexico's six major government healthcare institutions. With this most recent order, two of these six major institutions have
100% Drug Free, FDA Cleared Wearable for Widespread Relief from Chronic Pain WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell ® Wearable Pain Relief Technology ™ will be featured for the second year in a row at the American Podiatric Medical
